Jazz Pharmaceuticals (JAZZ) Retained Earnings (2010 - 2026)
Jazz Pharmaceuticals' quarterly Retained Earnings came in at -$651.0 million in Q1 2026, down 162.91% year-on-year from $1.0 billion in Q1 2025, and down 200.76% quarter-over-quarter from $646.1 million in Q4 2025.
Jazz Pharmaceuticals has reported Retained Earnings for 17 years, with the latest figure at -$651.0 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 162.91% year-over-year to -$651.0 million; the trailing twelve-month figure through Mar 2026 stood at -$651.0 million (down 162.91% YoY), and the FY2025 full-year result was $646.1 million, up 168.18% from the prior year.
- Retained Earnings for Q1 2026 stood at -$651.0 million, down from $646.1 million in the prior quarter.
- The five-year high for Retained Earnings was $1.0 billion in Q1 2025, with the low at -$1.6 billion in Q3 2022.
- Average Retained Earnings over 5 years is -$2.1 million, with a median of $442.7 million recorded in 2025.
- Year-over-year, Retained Earnings plunged 479.27% in 2022 and surged 188.15% in 2024.
- Tracing JAZZ's Retained Earnings over 5 years: stood at $733.6 million in 2022, then grew by 19.78% to $878.7 million in 2023, then plunged by 207.85% to -$947.7 million in 2024, then soared by 168.18% to $646.1 million in 2025, then plunged by 200.76% to -$651.0 million in 2026.
- The last three Retained Earnings figures came in at -$651.0 million (Q1 2026), $646.1 million (Q4 2025), and $442.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | -651.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -651.00 Mn |
| Dec 31, 2025 | 646.10 Mn |
| Sep 30, 2025 | 442.73 Mn |
| Jun 30, 2025 | -485.77 Mn |
| Mar 31, 2025 | 1.03 Bn |
| Dec 31, 2024 | -947.67 Mn |
| Sep 30, 2024 | 936.23 Mn |
| Jun 30, 2024 | -888.23 Mn |
| Mar 31, 2024 | 864.04 Mn |
| Dec 31, 2023 | 878.66 Mn |
| Sep 30, 2023 | 884.30 Mn |
| Jun 30, 2023 | 811.85 Mn |
| Mar 31, 2023 | -980.23 Mn |
| Dec 31, 2022 | 733.59 Mn |
| Sep 30, 2022 | -1.62 Bn |
| Jun 30, 2022 | -1.11 Bn |
| Mar 31, 2022 | -590.72 Mn |
| Dec 31, 2021 | 830.23 Mn |
| Sep 30, 2021 | -397.52 Mn |
| Jun 30, 2021 | -190.94 Mn |
| Mar 31, 2021 | 1.28 Bn |
| Dec 31, 2020 | -134.35 Mn |
| Sep 30, 2020 | -187.80 Mn |
| Jun 30, 2020 | -236.11 Mn |
| Mar 31, 2020 | -257.44 Mn |
| Dec 31, 2019 | -223.39 Mn |
| Sep 30, 2019 | 1.10 Bn |
| Jun 30, 2019 | -210.44 Mn |
| Mar 31, 2019 | -220.67 Mn |
| Dec 31, 2018 | -197.79 Mn |
| Sep 30, 2018 | 1.13 Bn |
| Jun 30, 2018 | 1.00 Bn |
| Mar 31, 2018 | -98.77 Mn |
| Dec 31, 2017 | -140.88 Mn |
| Sep 30, 2017 | -158.99 Mn |
| Jun 30, 2017 | -210.25 Mn |
| Mar 31, 2017 | -299.84 Mn |
| Dec 31, 2016 | 528.91 Mn |
| Sep 30, 2016 | 315.42 Mn |
| Jun 30, 2016 | -249.99 Mn |
| Mar 31, 2016 | 242.44 Mn |
| Dec 31, 2015 | 302.69 Mn |
| Sep 30, 2015 | -231.28 Mn |
| Jun 30, 2015 | -248.04 Mn |
| Mar 31, 2015 | -278.58 Mn |
| Dec 31, 2014 | 34.70 Mn |
| Sep 30, 2014 | -34.67 Mn |
| Jun 30, 2014 | 59.95 Mn |
| Mar 31, 2014 | 70.89 Mn |
| Dec 31, 2013 | 56.15 Mn |
| Sep 30, 2013 | -2.67 Mn |
| Jun 30, 2013 | 19.22 Mn |
| Mar 31, 2013 | 10.61 Mn |
| Dec 31, 2012 | 31.05 Mn |
| Sep 30, 2012 | 13.86 Mn |
| Jun 30, 2012 | -388,000.00 |
| Mar 31, 2012 | -322.20 Mn |
| Dec 31, 2011 | -31,000.00 |
| Sep 30, 2011 | -387.36 Mn |
| Jun 30, 2011 | -419.84 Mn |
| Dec 31, 2010 | -474.87 Mn |